- ANAC has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $14.8 million.
- ANAC has traded 187,809 shares today.
- ANAC is down 3.2% today.
- ANAC was up 5.5% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ANAC with the Ticky from Trade-Ideas. See the FREE profile for ANAC NOW at Trade-Ideas More details on ANAC: Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. ANAC has a PE ratio of 13.5. Currently there are 3 analysts that rate Anacor Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Anacor Pharmaceuticals has been 548,000 shares per day over the past 30 days. Anacor has a market cap of $1.0 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.30 and a short float of 11.1% with 10.67 days to cover. Shares are up 51.9% year-to-date as of the close of trading on Thursday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.